Two clients were signed.

The innovative technology will be cheap.

The dynamics look alarming.

The company received the exclusive right to sell two drugs.

The final decision has not yet been made.

The previously suspended agreement was revived.

Growth will be mainly in the north and south.

A draft decree has been prepared.

Mutually beneficial cooperation has become even more reliable.

Officially, there are no sanctions but they still exist.

The first batch will go to South Korea.

The project returned to the previous owner.

The European Court dismissed the claim.

The shipments were stalled.

It's expected to take a comprehensive set of measures.